Table 3.

Logistic regression for persistent LAC+ and/or aPL ≥ 40 (IgA, IgG, or IgM) and for persistent positive LAC and/or Sapporo criteria aPL (aCL or ß2-GPI IgG or IgM) ≥ 40 U.

OR95% CIp*
LAC+ and/or aPL ≥ 40 (IgA, IgG, or IgM)
  HCQ use0.210.05, 0.790.02
  Age at last followup1.00.96, 1.00.94
  Male sex2.30.34, 14.40.40
  Hispanic ethnicity3.10.84, 11.40.09
LAC+ and/or Sapporo criteria aPL (aCL or ß2-GPI IgG or IgM) ≥40 U
  HCQ use0.240.06, 0.940.04
  Hispanic ethnicity4.21.0, 16.70.04
  • * p values in bold type indicate statistical significance. aPL: antiphospholipid antibodies; LAC: lupus anticoagulant; ß2-GPI: ß2-glycoprotein I; Ig: immunoglobulin; aCL: anticardiolipin; HCQ: hydroxychloroquine.